DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Holdings Decreased by Ninety One UK Ltd

Ninety One UK Ltd lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.5% in the second quarter, HoldingsChannel.com reports. The firm owned 1,292,164 shares of the medical instruments supplier’s stock after selling 90,386 shares during the period. Ninety One UK Ltd’s holdings in DENTSPLY SIRONA were worth $32,188,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in the business. Raymond James Financial Services Advisors Inc. grew its position in shares of DENTSPLY SIRONA by 123.8% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 13,706 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 7,583 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $782,000. Louisiana State Employees Retirement System bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $456,000. abrdn plc boosted its position in DENTSPLY SIRONA by 40.0% during the 4th quarter. abrdn plc now owns 111,494 shares of the medical instruments supplier’s stock valued at $3,968,000 after purchasing an additional 31,852 shares during the period. Finally, CWM LLC boosted its position in DENTSPLY SIRONA by 18.2% during the 4th quarter. CWM LLC now owns 5,175 shares of the medical instruments supplier’s stock valued at $184,000 after purchasing an additional 796 shares during the period. Institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

XRAY has been the topic of several recent research reports. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, July 8th. The Goldman Sachs Group cut their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Monday, May 6th. Evercore ISI reduced their price target on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Finally, Stifel Nicolaus cut their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of “Moderate Buy” and a consensus price target of $33.44.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded down $1.20 on Tuesday, reaching $24.34. 1,018,815 shares of the company traded hands, compared to its average volume of 3,156,773. The stock has a market capitalization of $4.93 billion, a PE ratio of -55.95, a P/E/G ratio of 1.23 and a beta of 1.01. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The company’s 50 day moving average is $25.52 and its 200-day moving average is $29.17. DENTSPLY SIRONA Inc. has a fifty-two week low of $23.58 and a fifty-two week high of $38.36.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. During the same period in the prior year, the business posted $0.51 EPS. The company’s revenue for the quarter was down 4.3% compared to the same quarter last year. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.63%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction dated Friday, May 31st. The shares were acquired at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the acquisition, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.52% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.